Gibco GlutaMAX Supplement, for In-Vitro Diagnostic Use SKU 35050061
FDA Device Recall #Z-0174-2019 — Class II — August 24, 2018
Recall Summary
| Recall Number | Z-0174-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 24, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Life Technologies, Corp. |
| Location | Grand Island, NY |
| Product Type | Devices |
| Quantity | 1912 units |
Product Description
Gibco GlutaMAX Supplement, for In-Vitro Diagnostic Use SKU 35050061
Reason for Recall
Leaky bottles due to a defect in the bottle cap compromising the sterility of the product
Distribution Pattern
Nationwide: Foreign: Argentina Australia Canada China Great Britain Hong Kong India Japan Mexico Netherlands New Zealand Singapore South Korea Taiwan
Lot / Code Information
Lot Number: 1967697 (UDI 10190302001823) Exp. Date: 30-Jun-2020
Other Recalls from Life Technologies, Corp.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0171-2019 | Class II | Gibco MEM Non-Essential Amino Acids Solution (1... | Aug 24, 2018 |
| Z-0172-2019 | Class II | Gibco DPBS, calcium, magnesium, for In-Vitro Di... | Aug 24, 2018 |
| Z-0173-2019 | Class II | Gibco Sodium Pyruvate (100 mM) SKU 11360070, f... | Aug 24, 2018 |
| Z-2543-2018 | Class II | GIBCO CTS AIM V Serum-Free Media (SFM), Model N... | May 10, 2018 |
| Z-2545-2018 | Class II | Gibco Dulbecco's Modified Eagle Medium (DMEM), ... | May 10, 2018 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.